A new study published in the Journal of Aerosol Medicine and Pulmonary Drug Delivery showcases a potential breakthrough in lung pharmacokinetics (PK) research using the PExA® instrument developed by...
Read moreAs we reflect on the past year and look ahead to new possibilities, we want to extend our heartfelt thanks to our valued customers, partners and stakeholders. Your continued...
Read moreThe National Institute for Occupational Safety and Health (NIOSH), which was PExA’s first customer in the United States, has placed an order for an upgrade of their PExA 2.0...
Read morePExA AB (publ) (“PExA” or “the Company”) announces that one of the scientific papers based on results from the use of PExA’s technology has won an award at the...
Read morePExA AB (publ) (“PExA” or the “Company”) is participating for the second consecutive year at the European Respiratory Society (ERS) congress, one of the world’s largest congresses in respiratory...
Read more
